Yang, Yongrui
Ruan, Wenkai
Li, Jianlong
Dang, Rongpan
An, Huigang
Zhao, Wentao
Zhao, Yingxin
Xu, Liang
Tan, Hongdong
Wang, Huixue
Article History
Received: 1 March 2026
Accepted: 21 May 2026
First Online: 18 July 2026
Declarations
Declaration: All authors listed meet the authorship criteria according to the latest guidelines of the International Committee of Medical Journal Editors. All authors are in agreement with the manuscript.
Ethics approval and consent to participate: The portions of this study involving human participants, human materials. or human data were conducted in accordance with the Declaration of Helsinki and were approved by the Ethics committee of Shandong Public Health Clinical Center, Shandong University (approval number K2025137). All patients provided written informed consent, explicitly informed that the study aims to investigate the application and efficacy of retroperitoneoscopic debridement in lumbar infectious spondylodiscitis.
Consent for publication: Written informed consent was obtained from the patient for publication of this research and any accompanying images.
Competing interests: The authors declare no competing interests.